Jiangsu Jibeier Pharmaceutical Co Ltd (688566) — Cash Flow-to-Debt Ratio
Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥11.07 Million could theoretically repay 0% of its total liabilities (CN¥269.87 Million) in one year. Check total reinvestment intensity of Jiangsu Jibeier Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Jibeier Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Jiangsu Jibeier Pharmaceutical Co Ltd across 10 annual periods. Also explore Jiangsu Jibeier Pharmaceutical Co Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)
Year-by-year debt coverage analysis for Jiangsu Jibeier Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Jiangsu Jibeier Pharmaceutical Co Ltd (688566) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.93x | CN¥248.30 Million | CN¥267.47 Million | ▲ +18.0% |
| 2024 | 0.79x | CN¥215.29 Million | CN¥273.68 Million | ▲ +47.6% |
| 2023 | 0.53x | CN¥159.50 Million | CN¥299.25 Million | ▼ -4.4% |
| 2022 | 0.56x | CN¥150.72 Million | CN¥270.24 Million | ▼ -22.1% |
| 2021 | 0.72x | CN¥150.56 Million | CN¥210.40 Million | ▲ +4.2% |
| 2020 | 0.69x | CN¥117.36 Million | CN¥170.92 Million | ▼ -25.6% |
| 2019 | 0.92x | CN¥115.45 Million | CN¥125.16 Million | ▲ +13.3% |
| 2018 | 0.81x | CN¥97.97 Million | CN¥120.32 Million | ▼ -36.6% |
| 2017 | 1.28x | CN¥111.66 Million | CN¥86.92 Million | ▲ +289.1% |
| 2016 | 0.33x | CN¥39.29 Million | CN¥118.99 Million | — |